Catalyst Wire Dossier Catalyst Wire Dossier

Ovarest

Leuprolide · Enteris Biopharma Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ovarest, covering 2022-03-22 to 2022-03-22. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis [Phase 2]

See pricing